Induced Pluripotent Stem Cells Market: By Technology, By End User, and Geography      

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Induced Pluripotent Stem Cells Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Cryopreservation, and Cryopreservation), By End User (Academic Institutions, Research Institutes, Biotechnology Companies, and Others), and Region      

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Induced Pluripotent Stem Cells Market size was valued at US$ 1678.54 million in 2022. It is expected to reach a value of US$ 2876.72 million by 2029, growing at a CAGR of 8.0% from 2023-2029. Pluripotent stem cells are embryonic stem cells with the ability to develop into any adult cell type and aid in the repair of damaged tissues in the human body. Induced pluripotent stem cells, or iPSCs, are stem cells that have been genetically manipulated to act like pluripotent stem cells or embryonic stem cells. They can be collected from any tissue (typically skin or blood) from a child or an adult. The market for induced pluripotent stem cells is growing due to their ability to produce any cell or tissue the body requires. These cells can potentially be customized to provide a perfect genetic match for any patient suffering from diseases such as diabetes, spinal cord injury, leukaemia, or heart disease. Furthermore, these cells are really beneficial in comprehending. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Induced Pluripotent Stem Cells Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Induced Pluripotent Stem Cells Market Key Development:
  • In March 2015, FUJIFILM Holdings Corporation acquired Cellular Dynamics International, Inc.

summary download arrow Download Free Sample

Induced Pluripotent Stem Cells Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

8%

Largest Market

Europe

Fastest Growing Market

North-America

Induced Pluripotent Stem Cells Market Dynamics

The market for induced pluripotent stem cells (iPSCs) is driven by expanding adoption of stem cell therapies, a developing biotechnology sector with better funding, and the rising prevalence of chronic diseases. The wide range of clinical applications of induced pluripotent stem cells and increasing technological improvements of iPSCs are expected to boost the growth of the global induced pluripotent stem cells (iPSCs) market.

Induced Pluripotent Stem Cells Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 1678.54 million

Market Size in 2029

US$ 2876.72 million

Market CAGR

8%

By Technology

  • Cell Production
  • Cell Acquisition
  • Expansion and Sub-Culture
  • Cryopreservation

By End User

  • Academic Institutions
  • Research Institutes
  • Biotechnology Companies
  • Others

By Region

  • North America
  • Asia Pacific
  • LAMEA

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The induced pluripotent stem cells market size was valued at US$ 1678.54 million in 2022

The induced pluripotent stem cells market key players are: Acelity Holdings, Inc. (U.S) StemCells, Inc. (U.S) Japan Tissue Engineering Co., Ltd. (Japan) Organogenesis Inc (U.S) Fujifilm Holding Corporation (Japan) Fate Therapeutics (U.S) Bristol-Myers Squibb Company (U.S)

The induced pluripotent stem cells market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Induced Pluripotent Stem Cells Market Introduction 
2.1.Global Induced Pluripotent Stem Cells Market  - Taxonomy
2.2.Global Induced Pluripotent Stem Cells Market  - Definitions
2.2.1.Technology
2.2.2.End User
2.2.3.Geography
2.2.4.Region
3. Global Induced Pluripotent Stem Cells Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Induced Pluripotent Stem Cells Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Induced Pluripotent Stem Cells Market  By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Cell Production
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Cell Acquisition
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Expansion and Sub-Culture
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Cryopreservation
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6. Global Induced Pluripotent Stem Cells Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Academic Institutions
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Research Institutes
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Biotechnology Companies
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Induced Pluripotent Stem Cells Market  By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Asia Pacific
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. LAMEA
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Induced Pluripotent Stem Cells Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Induced Pluripotent Stem Cells Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cell Production
9.1.2.Cell Acquisition
9.1.3.Expansion and Sub-Culture
9.1.4.Cryopreservation
9.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Academic Institutions
9.2.2.Research Institutes
9.2.3.Biotechnology Companies
9.2.4.Others
9.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.North America
9.3.2.Asia Pacific
9.3.3.LAMEA
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Induced Pluripotent Stem Cells Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cell Production
10.1.2.Cell Acquisition
10.1.3.Expansion and Sub-Culture
10.1.4.Cryopreservation
10.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Academic Institutions
10.2.2.Research Institutes
10.2.3.Biotechnology Companies
10.2.4.Others
10.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.North America
10.3.2.Asia Pacific
10.3.3.LAMEA
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Induced Pluripotent Stem Cells Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cell Production
11.1.2.Cell Acquisition
11.1.3.Expansion and Sub-Culture
11.1.4.Cryopreservation
11.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Academic Institutions
11.2.2.Research Institutes
11.2.3.Biotechnology Companies
11.2.4.Others
11.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.North America
11.3.2.Asia Pacific
11.3.3.LAMEA
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Induced Pluripotent Stem Cells Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cell Production
12.1.2.Cell Acquisition
12.1.3.Expansion and Sub-Culture
12.1.4.Cryopreservation
12.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Academic Institutions
12.2.2.Research Institutes
12.2.3.Biotechnology Companies
12.2.4.Others
12.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.North America
12.3.2.Asia Pacific
12.3.3.LAMEA
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Induced Pluripotent Stem Cells Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Technology Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cell Production
13.1.2.Cell Acquisition
13.1.3.Expansion and Sub-Culture
13.1.4.Cryopreservation
13.2.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Academic Institutions
13.2.2.Research Institutes
13.2.3.Biotechnology Companies
13.2.4.Others
13.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.North America
13.3.2.Asia Pacific
13.3.3.LAMEA
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Acelity Holdings, Inc. (U.S)
14.2.2.StemCells, Inc. (U.S)
14.2.3.Japan Tissue Engineering Co., Ltd. (Japan)
14.2.4.Organogenesis Inc (U.S)
14.2.5.Fujifilm Holding Corporation (Japan)
14.2.6.Fate Therapeutics (U.S)
14.2.7.Bristol-Myers Squibb Company (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Acelity Holdings, Inc. (U.S)
  • StemCells, Inc. (U.S)
  • Japan Tissue Engineering Co., Ltd. (Japan)
  • Organogenesis Inc (U.S)
  • Fujifilm Holding Corporation (Japan)
  • Fate Therapeutics (U.S)
  • Bristol-Myers Squibb Company (U.S)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market